Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Die Ophthalmologie
Erschienen in: Der Ophthalmologe 2/2005

01.02.2005 | Weiterbildung · Zertifizierte Fortbildung

Makulaforamen

Überblick und aktuelle chirurgische Konzepte

verfasst von: PD Dr. S. Dithmar

Erschienen in: Die Ophthalmologie | Ausgabe 2/2005

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die bislang auf biomikroskopischen Beobachtungen beruhenden Vorstellungen zur Pathogenese des Makulaforamens haben sich durch die Weiterentwicklung der optischen Kohärenztomographie deutlich geändert. Die exakte Darstellung der vitreofovealen Pathologie zeigt, dass bei den verschiedenen Stadien der Erkrankung unterschiedliche Kraftvektoren wirken. Diese Erkenntnisse machen eine stadienangepasste operative Behandlung des Makulaforamens prinzipiell möglich. Einzelne chirurgische Schritte werden in der Literatur nach wie vor kontrovers diskutiert, es gibt noch keinen goldenen Standard für die operative Behandlung. Insbesondere besteht noch keine Einigkeit über den Nutzen einer chirurgischen Entfernung der Membrana limitans interna (ILM-Peeling) und der hierzu ggf. durchgeführten Indozyaningrünanfärbung. Auch die Art der Endotamponade und die ggf. postoperative Lagerung sind umstritten, sodass die operative Therapie der Erkrankung abhängig vom Operateur sehr variabel sein kann. In dieser Übersicht wird anhand der umfangreichen Literatur der aktuelle Kenntnisstand zu diesem Thema aufgezeigt.
Literatur
1.
Akiba J, Quiroz MA, Trempe CL (1990) Role of posterior vitreous detachment in idiopathic macular holes. Ophthalmology 97: 1610–1613
2.
Al-Abdulla NA, Thompson JT, Sjaarda RN (2004) Results of macular hole surgery with and without epiretinal dissection or internal limiting membrane removal. Ophthalmology 111: 142–149CrossRef
3.
Ando F, Sasano K, Ohba N et al. (2004) Anatomic and visual outcome after indocyanine green-assisted peeling of the retinal internal limiting membrane in idiopathic macular hole surgery. Am J Ophthalmol 137: 609–614CrossRefPubMed
4.
Avila MP, Jalkh AE, Murakami K et al. (1983) Biomicroscopic study of the vitreous in macular breaks. Ophthalmology 90: 1277–1283
5.
Balestrazzi A, Blasi MA, Scupola A et al. (2001) Retinal detachment due to macular hole after transpupillary thermotherapy of choroidal melanoma. Retina 21: 384–385CrossRef
6.
Banker AS, Freeman WR, Kim JW et al. (1997) Vision-threatening complications of surgery for full-thickness macular holes. Ophthalmology 104: 1442–1453
7.
Banker AS, Freeman WR, Kim JW et al. (1999) A multicentered clinical study of serum as adjuvant therapy for surgical treatment of macular holes. Arch Ophthalmol 117: 1499–1502
8.
Bechmann M, Mueller AJ, Gandorfer A et al. (2001) Macular hole surgery in an eye with an optic pit. Am J Ophthalmol 132: 263–264CrossRef
9.
Ben Simon GJ, Desatnik H, Alhalel A et al. (2004) Retrospective analysis of vitrectomy with and without internal limiting membrane peeling for stage 3 and 4 macular hole. Ophthalmic Surg Lasers Imaging 35: 109–115
10.
Benson WE, Cruickshanks KC, Fong DS et al. (2001) Surgical management of macular holes. Ophthalmology 108: 1328–1335CrossRefPubMed
11.
Boldt H, Munden P, Folk J, Mehaffey M (1996) Visual field defects after macular hole surgery. Am J Ophthalmol 122: 371–381
12.
Brooks HL Jr (2000) Macular hole surgery with and without internal limiting membrane peeling. Ophthalmology 107: 1939–1948CrossRefPubMed
13.
Burk SE, DaMata AP, Snyder ME et al. (2000) Indocyanine green-assisted peeling of the retinal internal limiting membrane. Ophthalmology 107: 2010–2014CrossRefPubMed
14.
Casuso LA, Scott IU, Flynn HW Jr et al. (2001) Long-term follow-up of unoperated macular holes. Ophthalmology 108: 1150–1155CrossRef
15.
Chan CK, Lawrence FC (2001) Macular hole after laser in situ kertomileusis and photorefractive keratectomy. Am J Ophthalmol 131: 666–667CrossRef
16.
Chan CK, Wessels IF, Friedrichsen EJ (1995) Treatment of idiopathic macular holes by induced posterior vitreous detachment. Ophthalmology 102: 757–767
17.
Chew EY, Sperduto RD, Hiller R et al. (1999) Clinical course of macular holes: the eye disease case-control study. Arch Ophthalmol 117: 242–246
18.
Christmas NJ, Smiddy WE, Flynn HW Jr (1998) Reopening of macular holes after initially successful repair. Ophthalmology 105: 1835–1838CrossRef
19.
Chuang LH, Lai CC, Yang KJ et al. (2001) A traumatic macular hole secondary to a high-energy Nd:YAG laser. Ophthalmic Surg Lasers 32: 73–75
20.
Ciardella AP, Schiff W, Barlie G et al. (2003) Persistent indocyanine green fluorescence after vitrectomy for macular hole. Am J Ophthalmol 136: 174–177CrossRefPubMed
21.
Ciulla TA, Topping TM (1997) Surgical treatment of a macular hole secondary to accidental laser burn. Arch Ophthalmol 115: 929–930
22.
Cohen SM, Gass JDM (1994) Macular hole following severe hypertensive retinopathy. Arch Ophthalmol 112: 878–879
23.
Costa RA, Cardillo JA, Morales MH et al. (2001) Optical coherence tomography evaluation of idiopathic macular hole treatment by gas-assisted posterior vitreous detachment. Am J Ophthalmol 132: 264–266CrossRef
24.
DaMata AP, Burk SE, Riemann CD et al. (2001) Indocyanine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for macular hole repair. Ophthalmology 108: 1187–1192CrossRefPubMed
25.
De Bustros S, The Vitrectomy for Prevention of Macular Hole Study Group (1994) Vitrectomy for prevention of macular holes. Ophthalmology 101: 1055–1060
26.
Degenring RF, Kamppeter B, Sauder G, Jonas JB (2004) Vorübergehende Visusminderung ohne Metamorphopsien. Ophthalmologe 101: 186–188CrossRef
27.
Drexler W (2004) Methodische Weiterentwicklungen. Hochauflösende OCT. Ophthalmologe 101: 804–812CrossRef
28.
Duker JS, Wendel R, Patel AC, Puliafito CA (1994) Late re-opening of macular holes after initially successful treatment with vitreous surgery. Ophthalmology 101: 1373–1378
29.
Eckardt C, Eckardt U, Gross S et al. (1997) Entfernung der Membrana limitans interna bei Makulalöchern. Klinische und morphologische Befunde. Ophthalmologe 94: 545–551CrossRef
30.
Engelbrecht NE, Freeman J, Sternberg P Jr et al. (2002) Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 133: 89–94CrossRefPubMed
31.
Ezra E, Gregor ZJ (2004) Surgery for idiopathic full-thickness macular hole: two-year results of a randomized clinical trial comparing natural history, vitrectomy, and vitrectomy plus autologous serum: Morfields Macular Hole Study Group Report no.1. Arch Ophthalmol 122: 224–226CrossRef
32.
Ezra E, Arden G, Riordan-Eva P et al. (1996) Visual field loss following vitrectomy for stages 2 and 3 macular holes. Br J Ophthalmol 80: 519–525
33.
Ezra E, Munro PM, Chartens DG et al. (1997) Macular hole opercula. Ultrastructural features and clinicopathologic correlation. Arch Ophthalmol 115: 1381–1387
34.
Ezra E, Wells JA, Gray RH et al. (1998) Incidence of idiopathic full-thickness macular holes in fellow eyes. A 5-year prospective natural history study. Ophthalmology 105: 353–359
35.
Ezra E, Fariss RN, Possin DE et al. (2001) Immunology to chemical characterization of macular hole opercula. Arch Ophthalmol 119: 223–231
36.
Facino M, Mochi B, Lai S, Terrile R (2004) A simple way to prevent indocyanine green from entering the subretinal space during vitrectomy for retinal detachment due to myopic macular hole. Eur J Ophthalmol 14: 269–271
37.
Fekrat S, Wendel RT, Cruz Z de la, Green WR (1995) Clinicopathologic correlation of an epiretinal membrane associated with a recurrent macular hole. Retina 15: 53–57
38.
Flynn HW Jr (1994) Macular hole surgery in patients with proliferative diabetic retinopathy. Arch Ophthalmol 112: 877–878
39.
Frangieh GT, Green WR, Engel HM (1981) A histopathologic study of macular cysts and holes. Retina 1: 311–336
40.
Freeman WR, Azen SP, Kim JW et al. (1997) Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes: results of a multicentered randomized clinical trial. Arch Ophthalmol 115: 11–21
41.
Gandorfer A, Haritoglou C, Gass CA et al. (2001) Indocyanine green-assisted peeling of the internal limiting membrane may cause retinal damage. Am J Ophthalmol 132: 431–433CrossRefPubMed
42.
Gandorfer A, Haritoglou C, Gandorfer A, Kampik A (2003) Retinal damage from indocyanine green in experimental macular surgery. Invest Ophthalmol Vis Sci 44: 316–323CrossRefPubMed
43.
Gass JD (1988) Idiopathic senile macular hole. Its early stages and pathogenesis. Arch Ophthalmol 106: 629–639
44.
Gass JD (1995) Das altersabhängige idiopathische Makulaforamen. Ophthalmolge 92: 617–625
45.
Gass JD (1995) Reappraisal of biomicroscopic classification of stages of development of a macular hole. Am J Ophthalmol 119: 752–759
46.
Gass JDM (1999) Mueller cell cone, an overlooked part of the anatomy of the fovea centralis: hypotheses concerning its role in the pathogenesis of macular hole and foveomacular retinoschisis. Arch Ophthalmol 117: 821–823
47.
Gass CA, Haritoglou C, Schaumberger M, Kampik A (2003) Functional outcome of macular hole surgery with and without indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol 241: 716–720
48.
Gaudric A, Massin P, Paques M et al. (1995) Autologoues platelet concentrate for the treatment of full-thickness macular holes. Graefes Arch Clin Exp Ophthalmol 233: 549–554CrossRef
49.
Gaudric A, Haouchine B, Massin P et al. (1999) Macular hole formation. Arch Ophthalmol 117: 744–751
50.
Ghoraba H (2002) Types of macular holes encountered during diabetic vitrectomy. Retina 22: 176–182CrossRef
51.
Glaser BM, Michels RG, Kuppermann BD et al. (1992) Transforming growth factor-β 2 for the treatment of full-thickness macular holes: a prospective randomized study. Ophthalmology 99: 1162–1173
52.
Goldbaum MH, McCuen BW, Hanneken AM et al. (1998) Silicone oil tamponade to seal macular holes without position restrictions. Ophthalmology 105: 2140–2148CrossRef
53.
Grisanti S, Szurman P, Gelisken F et al. (2004) Histologic findings in experimental macular surgery with indocyanine green. Invest Ophthalmol Vis Sci 45: 282–286CrossRefPubMed
54.
Guex-Crosier Y (1999) The pathogenesis and clinical presentation of macular edema in inflammatory diseases. Doc Ophthalmol 97: 297–309CrossRef
55.
Guyer DR, Green WR, DeBustros S, Fine SL (1990) Histopathologic features of idiopathic macular holes and cysts. Ophthalmology 97: 1045–1051
56.
Hagemann LF, Costa RF, Ferreira HM, Farah ME (2003) Optical coherence tomography of a traumatic neodymium:YAG laser-induced macular hole. Ophthalmic Surg Lasers 34: 57–59
57.
Haouchine B, Massin P, Gaudric A (2001) Foveal pseudocyst as the first step in macular hole formation: a prospective study by optical coherence tomography. Ophthalmology 108: 15–22CrossRef
58.
Haritoglou C, Gass CA, Schaumberger M et al. (2001) Macular changes after peeling of the internal limiting membrane in macular hole surgery. Am J Ophthalmol 132: 363–368CrossRef
59.
Haritoglou C, Gandorfer A, Gass CA et al. (2002) Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathologic correlation. Am J Ophthalmol 134: 836–841CrossRefPubMed
60.
Haritoglou C, Gass CA, Schaumberger M et al. (2002) Long-term follow-up after macular hole surgery with internal limiting membrane peeling. Am J Ophthalmol 134: 661–666CrossRefPubMed
61.
Haritoglou C, Gandorfer A, Gass CA et al. (2003) The effect of indocyanine green on functional outcome of macular pucker surgery. Am J Ophthalmol 135: 328–337CrossRefPubMed
62.
Haritoglou C, Gandorfer A, Schaumberger M et al. (2003) Light-absorbing properties and osmolarity of indocyanine-green depending on concentration and solvent medium. Invest Ophthalmol Vis Sci 44: 2722–2729CrossRef
63.
Haritoglou C, Neubauer AS, Gandorfer A et al. (2003) Indocyanine green for successful repair of a long-standing macular hole. Am J Ophthalmol 136: 389–391CrossRef
64.
Haritoglou C, Gandorfer A, Gass C, Kampik A (2004) Histology of the vitreoretinal interface after staining of the internal limiting membrane using glucose 5% diluted indocyanine and infracyanine green. Am J Ophthalmol 137: 345–348CrossRef
65.
Hassenstein A, Scholz F, Richard G (2004) OCT bei Makulaforamen. Ophthalmologe 101: 777–784
66.
Hee MR, Puliafito CA, Wong C et al. (1995) Optical coherence tomography of macular holes. Ophthalmology 102: 748–756
67.
Hikichi T, Yoshida A, Akiba J, Trempe CL (1995) Natural outcome of stage 1, 2, 3, and 4 idiopathic macular holes. Br J Ophthalmol 79: 517–520
68.
Ho JD, Tsai RJF, Chen SN, Chen HC (2003) Cytotoxicity of indocyanine green on retinal pigment epithelium. Arch Ophthalmol 121: 1423–1429CrossRef
69.
Horiguchi M, Nagata S, Yamamoto N et al. (2003) Kinetics of indocyanine green dye after intraocular surgeries using indocyanine green staining. Arch Ophthalmol 121: 327–331
70.
Horio N, Horiguchi M (2004) Effect on visual outcome after macular hole surgery when staining the internal limiting membrane with indocyanine green dye. Arch Ophthalmol 122: 992–996CrossRef
71.
Hsuan JD, Brown NA, Bron AJ et al. (2001) Posterior surgery and nuclear cataract after vitrectomy. J Cataract Refract Surg 27: 437–444CrossRef
72.
Hutton W, Fuller D, Snyder W et al. (1996) Visual field defects after macular hole surgery. Ophthalmology 103: 2152–2159
73.
Imai M, Iijima H, Gotoh T et al. (1999) Optical coherence tomography of successful repaired idiopathic macular holes. Am J Ophthalmol 128: 621–627CrossRef
74.
Imai M, Obshiro T, Gotoh T et al. (2003) Spontaneous closure of stage 2 macular hole observed with optical coherence tomography. Am J Ophthalmol 136: 187–188CrossRef
75.
Ip MS, Baker BJ, Duker JS et al. (2002) Anatomical outcomes of surgery for idiopathic macular hole as determined by optical coherence tomography. Arch Ophthalmol 120: 29–35
76.
Isomae T, Sato Y, Shimada H (2001) Shortening the duration of prone positioning after macular hole surgery—comparison between one week and one day. Jpn J Ophthalmol 46: 84–88CrossRef
77.
Jaycoock PD, Laidlaw DAH (2004) Membrane peeling and indocyanine green. Ophthalmology 111: 1433–1434CrossRef
78.
Kadonosono K, Itoh N, Uchio E et al. (2000) Staining of internal limiting membrane in macular hole surgery. Arch Ophthalmol 118: 1116–1118
79.
Kakehashi A, Schepens CL, Trempe CL (1996) Vitreomacular observations, II: data on the pathogenesis of idiopathic macular breaks. Graefes Arch Clin Exp Ophthalmol 234: 425–433
80.
Kang HK, Chang AA, Beaumont PE (2000) The macular hole: report of an Australian surgical series and meta-analysis of the literature. Clin Exp Ophthalmol 28: 298–308CrossRef
81.
Kang SW, Ahn K, Ham Dl (2003) Types of macular hole closure and their clinical implications. Br J Ophthalmol 87: 1015–1019CrossRef
82.
Kasuga Y, Arai J, Akimoto M, Yoshimura N (2000) Optical coherence tomography to confirm early closure of macular holes. Am J Ophthalmol 130: 675–676CrossRef
83.
Kelly NE, Wedel RE (1991) Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch Ophthalmol 109: 654–659
84.
Kerrison J, Haller J, Elman M, Miller N (1996) Visual field loss following vitreous surgery. Arch Ophthalmol 114: 564–569
85.
Kim JW, Freeman WR, El-Haig W et al. (1995) Baseline characteristics, natural history, and risk factors to progression in eyes with stage 2 macular holes: results from a prospective randomized clinical trial. Ophthalmology 102: 1818–1829
86.
Kim JW, Freeman WR, Azen SP et al. (1996) Prospective randomized trial of vitrectomy or observation for stage 2 macular holes. Am J Ophthalmol 121: 605–614
87.
Kimura H, Kuroda S, Nagata M (2004) Triamcinolone acetonide-assited peeling of the internal limiting membrane. Am J Ophthalmol 137: 172–173
88.
Kitaya N, Hikichi T, Kagokawa H et al. (2004) Irregularity of photoreceptor layer after successful macular hole surgery prevents visual acuity improvement. Am J Ophthalmol 138: 308–310CrossRef
89.
Korobelnik JF, Hannouche D, Belayachi N et al. (1996) Autologous platelet concentrate as an adjunct in macular hole healing: a pilot study. Ophthalmology 103: 590–594
90.
Kumar A, Prakash G, Singh RP (2002) Indocyanine green enhanced maculorhexis in macular hole surgery. Indian J Ophthalmol 50: 123–126
91.
Kusaka S, Hayashi N, Ohji M et al. (2003) Macular hole secondary to fungal endophthalmitis. Arch Ophthalmol 121: 732–733CrossRef
92.
Kwok AKH, Li WWY, Pang CP (2001) Indocyanine green staining and removal of internal limiting membrane in macular hole surgery: histology and outcome. Am J Ophthalmol 132: 178–183CrossRef
93.
Lai JC, Stinnett SS, McCuen BW (2003) Comparison of silicone oil versus gas tamponade in the treatment of idiopathic full-thickness macular hole. Ophthalmology 110: 1170–1174CrossRef
94.
Lee BL (2000) Vitrectomy for proliferative diabetic retinopathy and macular hole. Ann Ophthalmol 32: 144–145
95.
Lewis ML, Cohen SM, Smiddy WE, Gass JD (1996) Bilaterality of idiopathic macular holes. Graefes Arch Clin Exp Ophthalmol 234: 241–245CrossRef
96.
Li K, Wong D, Hiscott P et al. (2003) Trypan blue staining of internal limiting membrane and epiretinal membrane during vitrectomy: visual results and histopathologic findings. Br J Ophthalmol 87: 216–219CrossRef
97.
Liebovitch I, Azmon B, Pianka P et al. (2003) Macular hole secondary to branch retinal vein occlusion diagnosed by retinal thickness analyzer. Ophthalmic Surg Lasers 34: 53–56
98.
Lochhead J, Jones E, Chui D et al. (2004) Outcome of ICG-assisted ILM peel in macular hole surgery. Eye 18: 804–808CrossRefPubMed
99.
Madreperla SA, McCuen BW, Hickinbotham D, Green WR (1995) Clinicopathologic correlation of surgically removed macular hole opercula. Am J Ophthalmol 120: 197–207
100.
Margherio RR, Margherio AR, Williams GA et al. (2000) Effect of perifoveal tissue dissection in the management of acute idiopathic full-thickness macular holes. Arch Ophthalmol 118: 495–498
101.
Melberg N, Meredith T (1996) Success with macular hole surgery. Ophthalmology 103: 201
102.
Messmer EM, Heidenkummer H-P, Kampik A (1998) Ultrastructure of epiretinal membranes associated with macular holes. Graefes Arch Clin Exp Ophthalmol 236: 248–254CrossRefPubMed
103.
Mester V, Kuhn F (2000) Internal limiting membrane removal in the management of full-thickness macular holes. Am J Ophthalmol 129: 769–777CrossRef
104.
Mete VO, Karaasian C, Ozbilgin MK et al. (1996) Alport syndrome with bilateral macular hole. Acta Ophthalmol Scand 74: 77–80
105.
Müller AJ, Klinger K, Tribus C, Kampik A (2004) Kombinierte Vorder- und Hinterabschnittschirurgie. Ophthalmologe 101: 667–674
106.
Nork TM, Gioia VM, Hobson RR, Kessel RH (1991) Subhyaloid hemorrhage illustrating a mechanism of macular hole formation. Arch Ophthalmol 109: 884–885
107.
Olsen TW, Sternberg P, Martin DF et al. (1996) Postoperative hypopyon after intravitreal bovine thrombin for macular hole surgery. Am J Ophthalmol 121: 575–577
108.
Olsen TW, Sternberg P, Capone A Jr et al. (1998) Macular hole surgery using thrombin-activated fibrinogen and selective removal of the internal limiting membrane. Retina 18: 322–329
109.
Paques M, Chastang C, Mathis A et al. (1999) Effect of autologous platelet concentrate in surgery for idiopathic macular hole: results of a multicenter, doublemasked, randomized trial. Platelets in Macular Hole Surgery Group. Ophthalmology 106: 932–938CrossRef
110.
Paques M, Massin P, Blain P et al. (2000) Long-term incidence of reopening of macular holes. Ophthalmology 107: 760–766CrossRef
111.
Park SS, Marcus DM, Duker JS et al. (1995) Posterior segment complications after vitrectromy for macular hole. Ophthalmology 102: 775–781
112.
Park DW, Sipperley JO, Sneed SR et al. (1999) Macular hole surgery with internal-limiting membrane peeling and intravitreous air. Ophthalmology 106: 1392–1398CrossRef
113.
Patterson JA, Ezra E, Gregor ZJ (2001) Acute full-thickness macular hole after uncomplicated phacoemulsification cataract surgery. Am J Ophthalmol 131: 799–800CrossRef
114.
Pearce IA, Branley M, Groenewald C et al. (1998) Visual function and patient satisfaction after macular hole surgery. Eye 12: 651–658
115.
Pendergast S, McCuen BI (1996) Visual field loss after macular hole surgery. Ophthalmology 103: 1069–1077
116.
Perrier M, Sebag M (2003) Trypan blue-assisted peeling of the internal limiting membrane during macular hole surgery. Am J Ophthalmol 135: 903–905CrossRef
117.
Pertile G, Claes C (1999) Silicone oil vs. gas for the treatment of full-thickness macular hole. Bull Soc Belge Ophthalmol 274: 31–36
118.
Polk TD, Smiddy WE, Flynn HW Jr (1996) Bilateral visual function after macular hole surgery. Ophthalmology 103: 422–426
119.
Posselt D, Rahman R, Smith M, Simcock PR (2004) Visual outcome following ICG assisted ILM peel for macular hole. Eye (Epub ahead of print)
120.
Rao PK, Shah G, Blinder KJ (2002) Bilateral macular hole formation in a patient with retinitis pigmentosa. Ophthalmic Surg Lasers 33: 152–154
121.
Reese AB, Jones IS, Cooper WC (1967) Macular changes secondary to vitreous traction. Am J Ophthalmol 64: 544–549
122.
Rivett K, Kruger L, Radloff S (2004) Infracyanine-assisted internal limiting membrane peeling in macular hole repair: does it make a difference? Graefes Arch Clin Exp Ophthalmol 242: 393–396CrossRef
123.
Sakamoto T, Itaya K, Noda Y, Ishibashi T (2002) Retinal pigment epithelial changes after indocyanine green-assisted vitrectomy. Retina 22: 794–796CrossRefPubMed
124.
Schepens CL (1955) Fundus changes caused by alterations of the vitreous body. Am J Ophthalmol 106: 629–939
125.
Schmidt JC, Rodrigues EB, Meyer CH et al. (2004) A modified technique to stain the internal limiting membrane with indocyanine green. Ophthalmologica 218: 176–179CrossRef
126.
127.
Scott RA, Ezra E, West JF, Gregor ZJ (2000) Visual and anatomical results of surgery for long standing macular holes. Br J Ophthalmol 84: 150–153CrossRefPubMed
128.
Sheidow TG, Gonder JR (1998) Macular hole secondary to retrobulbar needle perforation. Retina 18: 178–180
129.
Sheidow TG, Blinder KJ, Holekamp N et al. (2003) Outcome results in macular hole surgery. An evaluation of internal limiting membrane peeling with and without indocyanine green. Ophthalmology 110: 1697–1701CrossRefPubMed
130.
Simcock PR, Scalia S (2001) Phacovitrectomy without prone posture for full thickness macular holes. Br J Ophthalmol 85: 1316–1319CrossRef
131.
Sippy BD, Engelbrecht NE, Hubbard GB et al. (2001) Indocyanine green effect on cultured human retinal pigment epithelial cells—implication for macular hole surgery. Am J Ophthalmol 132: 433–435CrossRefPubMed
132.
Sjaarda R, Glaser B, Thompson J et al. (1995) Distribution of iatrogenic retinal breaks in macular hole surgery. Ophthalmology 102: 1387–1392
133.
Slaughter K, Lee IL (2004) Macular hole surgery with and without indocyanine green assistance. Eye 18: 376–378CrossRef
134.
Smiddy WE, Flynn HW (2003) Pathogenesis of macular holes and therapeutic implications. Am J Ophthalmol 137: 525–537CrossRef
135.
Smiddy WE, Glaser BM, Thompson JT et al. (1993) Transforming growth factor-beta 2 significantly enhances the ability to flatten the rim of subretinal fluid surrounding macular holes: preliminary anatomic results of a multicenter prospective randomized study. Retina 13: 296–301
136.
Smiddy WE, Pimentel S, Williams GA (1997) Macular hole surgery without using adjunctive additives. Ophthalmic Surg Lasers 28: 713–717
137.
Smiddy WE, Feuer W, Cordahi G (2001) Internal limiting membrane peeling in macular hole surgery. Ophthalmology 108: 1471–1476CrossRefPubMed
138.
Spaide RF (2000) Closure of an outer lamellar macular hole by vitrectomy: hypothesis for one mechanism of macular hole formation. Retina 20: 587–590
139.
Spaide RF (2002) Macular hole repair with minimal vitrectomy. Retina 22: 183–186CrossRef
140.
Stalmans P, Parys-Vanginderdeuren R, De Vos R, Feron EJ (2001) ICG staining of the internal limiting membrane facilitates its removal during surgery for macular holes and puckers. Bull Soc Belge Ophthalmol 281: 21–26
141.
Stalmans P, Van Eken EH, Veckeneer M (2002) Toxic effect of indocyanine green on retinal pigment epithelium related to osmotic effects of the solvent. Am J Ophthalmol 134: 282–285CrossRef
142.
Staudt S, Miller DW, Unnebrink K, Holz FG (2003) Inzidenz und Ausprägung von postoperativem Makulaödem nach Makulaforamenoperation mit und ohne kombinierte Kataraktoperation. Ophthalmologe 100: 702–707CrossRefPubMed
143.
Szurman P, Di Tizio FM, Lafaut B et al. (2000) Stellenwert der postoperativen Positionierung in der Chirurgie des idiopathischen Makulaforamens—kontrollierte konsekutive Studie. Klin Monatsbl Augenheilkd 217: 351–355CrossRef
144.
Tadayoni R, Paques M, Girmens JF et al. (2003) Persistence of fundus fluorescence after use of indocyanine green for macular surgery. Ophthalmology 110: 604–608CrossRefPubMed
145.
Takasu I, Shiraga F, Otsuki H (2004) Triamcinolone aetonide-assisted internal limiting membrane peeling in macular hole surgery. Retina 24: 620–622CrossRef
146.
Tanner V, Williamson TH (2000) Watzke-Allen slit beam test in macular holes confirmed by optical coherence tomography. Arch Ophthalmol 118: 1059–1063
147.
Tashimo A, Mitamura Y, Ohtsuka K et al. (2003) Macular hole formation following ruptured retinal arterial macroaneurysm. Am J Ophthalmol 135: 487–492CrossRef
148.
Terasaki H, Miyake Y, Nomura R et al. (2001) Focal macular ERGs in eyes after removal of macular ILM during macular hole surgery. Invest Ophthalmol Vis Sci 42: 229–234PubMed
149.
Thompson JT, Sjaarda RN (2000) Results of macular hole surgery in patients over 80 years of age. Retina 20: 433–438CrossRef
150.
Thompson JT, Smiddy WE, Glaser BM et al. (1996) Intraocular tamponade duration and success of macular hole surgery. Retina 16: 373–382
151.
Thompson JT, Smiddy WE, Williams GA et al. (1998) Comparison of recombinant transforming growth factor-beta-2 and placebo as an adjunctive agent for macular hole surgery. Ophthalmology 105: 700–706CrossRef
152.
153.
Tornambe PE, Poliner LS, Grotke K (1997) Macular hole surgery without face-down positioning: a pilot study. Retina 17: 179–185
154.
Tornambe PE, Poliner LS, Cohen RG (1998) Definition of macular hole surgery end points: elevated/open, flat/open, flat/closed. Retina 18: 286–287
155.
Van de Moere A, Stalmans P (2003) Anatomical and visual outcome of macular hole surgery with infracyanine green-assisted peeling of the internal limiting membrane, endodrainage, and silicone oil tamponade. Am J Ophthalmol 136: 879–887CrossRef
156.
Vine AD, Johnson MW (1996) Thrombin in the management of full-thickness macular holes. Retina 16: 474–478
157.
Weinberger AW, Schlossmacher B, Dahlke C et al. (2002) Indocyanine-green-assisted internal limiting membrane peeling in macular hole surgery—a follow up study. Graefes Arch Clin Exp Ophthalmol 240: 913–917PubMed
158.
Weinberger AW, Dahlke C, Schlossmacher B et al. (2004) Internal limiting membrane staining with various concentration of indocyanine green dye. Am J Ophthalmol 137: 589CrossRef
159.
Welch JC (1997) Dehydration injury as a possible cause of visual field defect after pars plana vitrectomy for macular hole. Am J Ophthalmol 124: 698–699
160.
Wells JA, Gregor ZJ (1996) Surgical treatment of full-thickness macular holes using autologous serum. Eye 10: 593–599
161.
Wolf S, Reichel MB, Wiedemann P, Schnurrbusch UEK (2003) Clinical findings in macular hole surgery with indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol 241: 589–592CrossRef
162.
Yan H, Dhurjon L, Chow D et al. (1998) Visual field defect after pars plana vitrectomy. Ophthalmology 105: 1612–1616CrossRef
163.
Yoon H-S, Brooks HL, Capone A (1996) Ultrastructural features of tissue removed during idiopathic macular hole surgery. Am J Ophthalmol 122: 67–75
164.
Yuzawa M, Watanabe A, Takahashi Y, Matsui M (1994) Observation of idiopathic full-thickness macular holes. Arch Ophthalmol 112: 1051–1056
Metadaten
Titel
Makulaforamen
Überblick und aktuelle chirurgische Konzepte
verfasst von
PD Dr. S. Dithmar
Publikationsdatum
01.02.2005
Verlag
Springer-Verlag
Erschienen in
Die Ophthalmologie / Ausgabe 2/2005
Print ISSN: 2731-720X
Elektronische ISSN: 2731-7218
DOI
https://doi.org/10.1007/s00347-004-1155-5

Weitere Artikel der Ausgabe 2/2005

Der Ophthalmologe 2/2005 Zur Ausgabe

Bild und Fall

Akute unilaterale Visusminderung

Einführung zum Thema

Morbus Best

Übersicht

OCT bei epiretinaler Gliose

Originalien

Konfokale In-vivo-Hornhautmikroskopie nach Keratoplastik

Originalien

Evaluation des mobilen TGDc-01-Tonometers und Vergleich mit dem Applanationstonometer nach Goldmann

Leitthema

Funktion des Bestrophins

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen